Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 44 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib				Phase III				EGF110656 EGF110656-TRIO-CIRG 013, NCT00680901
	Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer				Phase II, Phase I				VU-VICC-GI-0622 VICC-GI-0622, 6980, NCI-6980, NCT00397384
	Evaluation of Single Session Stereotactic Body Radiotherapy				Phase II, Phase I				2005-0445 NCT00492817
	Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors				Phase II, Phase I				CTCT 06-11 NCT00493883
	Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)				Phase II, Phase I				ID02-446 NCT00508443
	Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients				Phase II, Phase I				2004-0290 NCT00526110
	Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer				Phase II, Phase I				Pro00002207 SPS 151596, NCT00578071
	Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus				Phase II				BC-ES-2 NCT00003487
	Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors				Phase II				NHLBI-99-H-0064 NCT00003839
	Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer				Phase II				NCI-04-C-0273 NCI-6332, DELCATH-G990039, NCT00096083


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute